Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated 1 day ago
GSK sees phase 3 win for Hansoh-partnered ADC in China as validating its ‘priority asset’
1 day ago
Hansoh Pharmaceutical’s pair of much-hyped ADCs continue to justify partner GSK’s decision...
Chutes & Ladders—Idorsia locks in new CEO after shakeup
1 day ago
After Idorsia’s former chief, Srishti Gupta, M.D., left the company upon “mutual...
Bausch + Lomb gives up on glaucoma eye drop hopeful after phase 2 fail
1 day ago
Bausch + Lomb has abandoned its next great hope in glaucoma after...
ARPA-H awards up to $160M to scientists developing custom genetic medicines
1 day ago
The Advanced Research Projects Agency for Health has awarded a new tranche...
Roche ends 2 Huntington’s disease programs, including Ionis-partnered tominersen
2 days ago
Roche has halted development on two of its Huntington’s disease prospects, marking...
Illumina names new commercial, legal chiefs as sequencing business shows signs of stability
2 days ago
Illumina has filled two key C-suite posts, naming Mike Sullivan as chief...
Fate’s off-the-shelf CAR-T therapy shows early promise in treatment-resistant autoimmune disease
2 days ago
“We were not expecting to see clinical responses so early,” Vaneet Sandhu...
Why biotech revenue projections ‘won’t look as sunny’ once Trump tax bill hits Medicaid enrollment
2 days ago
Insurance coverage losses caused by the Trump administration's tax and spend law...
GSK cuts losses on $700M upfront Alzheimer’s collab with Alector following 2 clinical failures
3 days ago
GSK has walked away from a $2.2 billion biobucks neurodegenerative disease pact...
FDA halts release of new drug rejection letters while working to formalize policy
3 days ago
The FDA has paused a controversial policy of releasing letters describing its...
Prime wins patent fight with Beam to continue work on AATD gene editing therapy
3 days ago
Prime Medicine has come out ahead in its patent dispute with fellow...
Satellos’ ‘intriguing’ Duchenne data raise hopes ahead of key readout
3 days ago
Satellos Bioscience has shared evidence that its Duchenne muscular dystrophy drug candidate...